Bausch Health Companies | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Amgen USD 1.69B 191M 2025-03
ANI Pharmaceuticals USD 76.53M 6.81M 2025-03
Aurora Cannabis CAD 38.18M 2.05M 2024-12
Bausch Health Companies USD 867M 47M 2025-03
Biogen USD 572.5M 104.8M 2025-03
Bristol-Myers Squibb USD 1.58B 521M 2025-03
Canopy Growth CAD 40.62M 308K 2024-12
Corcept Therapeutics USD 90.66M 7.29M 2025-03
Danaher USD 1.86B 165M 2025-03
Drreddys Laboratories INR 21.59B 436M 2024-12
Eli Lilly USD 2.36B 62.3M 2025-03
Gilead Sciences USD 1.26B 603M 2025-03
Novo Nordisk 16.11B 480M 2025-03
Pacira USD 86.78M 7.16M 2025-03
Perrigo USD 281.2M 46.4M 2025-03
Prestige Brands USD 64.05M 73K 2025-03
Supernus Pharmaceuticals USD 79.41M 9.66M 2024-12
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12
Zoetis USD 563M 62M 2025-03



Bausch Health Companies Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.